FIELD: chemistry.
SUBSTANCE: invention describes novel macrocyclic compounds of general formulae (I-c) (I-d), pharmaceutically acceptable salt or stereoisomer thereof, where R1 = -OR11 or -NH-SO2R12; R2 = hydrogen and R3 =C1-6-alkyl; n = 3-6; W is a radical of formula , where R5 = phenyl, possibly substituted with C1-6alkyl or alkoxy; thiazolyl, possibly substituted with C1-6alkyl; or pyridyl; R11 denotes hydrogen; R12 = C3-7-cycloalkyl, and a pharmaceutical composition containing said compounds.
EFFECT: said compounds are hepatitis C virus inhibitors and can be used in medicine.
3 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | 2006 |
|
RU2441870C2 |
HEPATITIS C VIRUS MACROCYCLIC INHIBITORS | 2006 |
|
RU2486189C2 |
MACROCYCLIC HEPATITIS C VIRUS INIHBITORS | 2006 |
|
RU2437886C2 |
PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS | 2008 |
|
RU2481340C2 |
MACROCYCLIC PHENYLCARBAMATES INHIBITING HCV | 2008 |
|
RU2490261C2 |
MACROCYCLIC INDOLE DERIVATIVES, APPLICABLE AS INHIBITORS OF HEPATITIS C VIRUS | 2009 |
|
RU2518471C2 |
MACROCYCLIC HEPATITIS TYPE C VIRUS INHIBITORS | 2006 |
|
RU2419619C2 |
PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDES | 2010 |
|
RU2553656C2 |
BIS-BENZIMIDAZOLE DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2540897C2 |
PHENYLETHYNYL DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2538507C2 |
Authors
Dates
2011-12-20—Published
2006-07-28—Filed